FDA Inspection
Zhejiang Starry Pharmaceutical Co. Ltd.Zhejiang Starry Pharmaceutical Co. Ltd. – FDA Inspection, Aug 2, 2019
Record Details
This FDA Inspection record concerns Zhejiang Starry Pharmaceutical Co. Ltd., with an inspection on August 2, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- Person
- Jay T. Wong (Issuing Officer)
View Company Profile
ID · 489fdd5b-31c0-4d9f-8ef2-36ac1fade7cd
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1098549
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Zhejiang Starry Pharmaceutical Co. Ltd.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| September 6, 2024 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Zhejiang Starry Pharmaceutical Co. Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.